These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 3499684)
1. Endothelium-derived relaxing factor from cultured human endothelial cells inhibits aggregation of human platelets. Alheid U; Frölich JC; Förstermann U Thromb Res; 1987 Sep; 47(5):561-71. PubMed ID: 3499684 [TBL] [Abstract][Full Text] [Related]
2. Human endothelial cells inhibit platelet aggregation by separately stimulating platelet cyclic AMP and cyclic GMP. Alheid U; Reichwehr I; Förstermann U Eur J Pharmacol; 1989 May; 164(1):103-10. PubMed ID: 2546782 [TBL] [Abstract][Full Text] [Related]
3. The effect of methylmercury (CH3HgCl) on the production of endothelium-derived relaxing factor (EDRF) by cultured human umbilical vascular endothelial cells based on its anti-aggregatory effect on human platelets. Ohno M; Kishimoto T; Tada M Cell Biol Toxicol; 1995 Dec; 11(6):303-11. PubMed ID: 8788207 [TBL] [Abstract][Full Text] [Related]
4. Endothelium-derived relaxing factor (EDRF): a defence mechanism against platelet aggregation and vasospasm in human coronary arteries. Förstermann U; Mügge A; Alheid U; Bode SM; Frölich JC Eur Heart J; 1989 Nov; 10 Suppl F():36-43. PubMed ID: 2620689 [TBL] [Abstract][Full Text] [Related]
5. Activation of guanylate cyclase and inhibition of platelet aggregation by endothelium-derived relaxing factor released from cultured cells. Hawkins DJ; Meyrick BO; Murray JJ Biochim Biophys Acta; 1988 May; 969(3):289-96. PubMed ID: 2897209 [TBL] [Abstract][Full Text] [Related]
7. Synergistic inhibition of platelet aggregation by endothelium-derived relaxing factor and prostacyclin. Macdonald PS; Read MA; Dusting GJ Thromb Res; 1988 Mar; 49(5):437-49. PubMed ID: 3287674 [TBL] [Abstract][Full Text] [Related]
8. Assessment of production of endothelium-derived relaxing factor (EDRF) by cultured human vascular endothelial cells based on its anti-aggregatory effect on human platelets. Ohno M; Kishimoto T; Jidoi J; Tada M Hum Cell; 1994 Mar; 7(1):68-71. PubMed ID: 8025024 [TBL] [Abstract][Full Text] [Related]
9. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Radomski MW; Palmer RM; Moncada S Br J Pharmacol; 1987 Nov; 92(3):639-46. PubMed ID: 3322462 [TBL] [Abstract][Full Text] [Related]
10. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Radomski MW; Palmer RM; Moncada S Br J Pharmacol; 1987 Sep; 92(1):181-7. PubMed ID: 3311265 [TBL] [Abstract][Full Text] [Related]
11. Assessment of production of endothelium-derived relaxing factor by cultured porcine cerebral microvessel endothelial cells. Kishimoto T; Oguri T; Matsumura K; Kawamoto K; Tada M Hum Cell; 1995 Mar; 8(1):19-24. PubMed ID: 7669748 [TBL] [Abstract][Full Text] [Related]
12. Methylene blue but not changes in cyclic GMP inhibits resting and bradykinin-stimulated production of prostacyclin by pig aortic endothelial cells. Martin W; Drazan KM; Newby AC Br J Pharmacol; 1989 May; 97(1):51-6. PubMed ID: 2541859 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of human platelet reactivity by endothelium-derived relaxing factor from human umbilical vein endothelial cells in suspension: blockade of aggregation and secretion by an aspirin-insensitive mechanism. Broekman MJ; Eiroa AM; Marcus AJ Blood; 1991 Aug; 78(4):1033-40. PubMed ID: 1868238 [TBL] [Abstract][Full Text] [Related]
14. Endothelium-derived relaxing factor inhibits thrombin-induced platelet aggregation by inhibiting platelet phospholipase C. Durante W; Kroll MH; Vanhoutte PM; Schafer AI Blood; 1992 Jan; 79(1):110-6. PubMed ID: 1309423 [TBL] [Abstract][Full Text] [Related]
15. Differential control and calcium-dependence of production of endothelium-derived relaxing factor and prostacyclin by pig aortic endothelial cells. White DG; Martin W Br J Pharmacol; 1989 Jul; 97(3):683-90. PubMed ID: 2547481 [TBL] [Abstract][Full Text] [Related]
16. Platelet inhibition by endothelium-derived relaxing factor from the rabbit perfused aorta. Bult H; Fret HR; Van den Bossche RM; Herman AG Br J Pharmacol; 1988 Dec; 95(4):1308-14. PubMed ID: 3064856 [TBL] [Abstract][Full Text] [Related]
17. Investigation of the existence and biological role of L-arginine/nitric oxide pathway in human platelets by spin-trapping/EPR studies. Prónai L; Ichimori K; Nozaki H; Nakazawa H; Okino H; Carmichael AJ; Arroyo CM Eur J Biochem; 1991 Dec; 202(3):923-30. PubMed ID: 1662618 [TBL] [Abstract][Full Text] [Related]
18. Endothelium-derived relaxing factor and atriopeptin II elevate cyclic GMP levels in pig aortic endothelial cells. Martin W; White DG; Henderson AH Br J Pharmacol; 1988 Jan; 93(1):229-39. PubMed ID: 2894877 [TBL] [Abstract][Full Text] [Related]
19. Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid. Ignarro LJ; Harbison RG; Wood KS; Kadowitz PJ J Pharmacol Exp Ther; 1986 Jun; 237(3):893-900. PubMed ID: 2872327 [TBL] [Abstract][Full Text] [Related]
20. Assessment of endothelium-derived relaxing factor from human coronary arteries using the anti-platelet aggregatory effect. Kishimoto T; Fukuzawa Y; Abe M; Hashimoto M; Tada M Nihon Eiseigaku Zasshi; 1992 Feb; 46(6):1043-50. PubMed ID: 1556827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]